Clinical Trial Update: Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study comparing pharmacodynamics and pharmacokinetics of biphasic insulin aspart 30 with insulin glargine and insulin glulisine in subjects with Type 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)
• Insulin Glargine (insulin glargine)
• Insulin glulisine (insulin glulisine)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED